Copyright
©The Author(s) 2025.
World J Gastroenterol. Mar 7, 2025; 31(9): 100271
Published online Mar 7, 2025. doi: 10.3748/wjg.v31.i9.100271
Published online Mar 7, 2025. doi: 10.3748/wjg.v31.i9.100271
Figure 6 Panaxadiol maintained the integrity of the intestinal epithelial barrier in mice with dextran sulfate sodium-induced colitis.
A: Alcian blue and periodic acid-Schiff staining (× 40); B-D: Immunohistochemistry analyses of claudin-1, occludin, and ZO-1 (× 100 magnification). Data are expressed as mean ± standard error of the mean (n = 8). aP < 0.05; bP < 0.01; DSS: Dextran sulfate sodium; PD: Panaxadiol.
- Citation: Qin Y, Zhang RY, Zhang Y, Zhao YQ, Hao HF, Wang JP. Network pharmacology and in vivo study: Unraveling the therapeutic mechanisms of Panax ginseng in potentially treating ulcerative colitis. World J Gastroenterol 2025; 31(9): 100271
- URL: https://www.wjgnet.com/1007-9327/full/v31/i9/100271.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i9.100271